Stock listing
NASDAQ:LABT Lakewood-Amedex Biotherapeutics Inc. Stock
Home listing (NASDAQ) of Lakewood-Amedex Biotherapeutics Inc.
Follow Lakewood-Amedex Biotherapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:LABT
$0.583 USD +0.003 (+0.6%)
Close on Oct 19, 2026
- Day range
- $0.560 – $0.667 USDOct 19, 2026
- Volume
- 92,404 sharesOct 19, 2026
- Market cap
- $1.38M USDAt the close on Oct 19, 2026 · price × 2.37M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LABT · Home | $0.583 USD | +0.003 (+0.6%) | 92,404 | $0.580 | $0.667 | $0.560 | $0.580 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:LABT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.583 | +0.003 | +0.6% | $0.580 | $0.667 | $0.560 | 92,404 | |
| $0.580 | -0.032 | -5.3% | $0.630 | $0.630 | $0.580 | 63,426 | |
| $0.612 | -0.019 | -3.1% | $0.600 | $0.628 | $0.581 | 147,836 | |
| $0.632 | -0.062 | -9.0% | $0.691 | $0.710 | $0.621 | 135,338 | |
| $0.694 | -0.037 | -5.1% | $0.727 | $0.727 | $0.666 | 149,019 | |
| $0.731 | -0.051 | -6.5% | $0.770 | $0.774 | $0.730 | 135,973 | |
| $0.782 | -0.010 | -1.2% | $0.793 | $0.821 | $0.780 | 118,134 | |
| $0.792 | -0.058 | -6.8% | $0.815 | $0.825 | $0.780 | 225,459 | |
| $0.850 | -0.020 | -2.3% | $0.780 | $0.900 | $0.761 | 8,498,672 | |
| $0.870 | +0.020 | +2.4% | $0.860 | $0.870 | $0.830 | 149,700 | |
| $0.850 | -0.080 | -8.6% | $0.880 | $0.890 | $0.820 | 272,200 | |
| $0.930 | 0.000 | 0.0% | $0.930 | $0.950 | $0.910 | 120,500 | |
| $0.930 | -0.030 | -3.1% | $0.940 | $0.960 | $0.910 | 170,300 | |
| $0.960 | -0.030 | -3.0% | $0.970 | $0.980 | $0.920 | 401,800 | |
| $0.990 | -0.160 | -13.9% | $1.090 | $1.090 | $0.920 | 1,288,600 | |
| $1.150 | -0.520 | -31.1% | $2.060 | $2.130 | $1.100 | 35,362,700 | |
| $1.670 | -0.160 | -8.7% | $1.850 | $1.850 | $1.630 | 176,000 | |
| $1.830 | +0.050 | +2.8% | $1.760 | $1.850 | $1.690 | 101,500 | |
| $1.780 | -0.210 | -10.6% | $1.970 | $2.000 | $1.780 | 109,800 | |
| $1.990 | -0.060 | -2.9% | $2.080 | $2.100 | $1.900 | 128,400 | |
| $2.050 | +0.060 | +3.0% | $1.990 | $2.080 | $1.920 | 361,800 | |
| $1.990 | +0.130 | +7.0% | $1.920 | $2.150 | $1.890 | 281,200 | |
| $1.860 | -0.230 | -11.0% | $2.040 | $2.050 | $1.840 | 125,200 | |
| $2.090 | -0.080 | -3.7% | $2.180 | $2.180 | $2.080 | 54,500 | |
| $2.170 | +0.050 | +2.4% | $2.170 | $2.170 | $2.070 | 97,300 | |
| $2.120 | -0.100 | -4.5% | $2.250 | $2.280 | $2.060 | 56,400 | |
| $2.220 | +0.170 | +8.3% | $2.110 | $2.230 | $2.030 | 141,000 | |
| $2.050 | -0.270 | -11.6% | $2.240 | $2.300 | $2.030 | 286,600 | |
| $2.320 | +0.140 | +6.4% | $2.200 | $2.610 | $2.130 | 5,084,500 | |
| $2.180 | +0.300 | +16.0% | $1.890 | $2.270 | $1.890 | 500,000 | |
| $1.880 | -0.020 | -1.1% | $1.880 | $1.980 | $1.870 | 90,200 | |
| $1.900 | -0.170 | -8.2% | $2.100 | $2.160 | $1.860 | 251,200 | |
| $2.070 | -0.690 | -25.0% | $2.470 | $2.640 | $2.060 | 509,100 | |
| $2.760 | +0.260 | +10.4% | $2.680 | $2.860 | $2.530 | 3,568,500 | |
| $2.500 | +0.200 | +8.7% | $2.230 | $2.580 | $2.220 | 13,655,500 | |
| $2.300 | -0.190 | -7.6% | $2.440 | $2.440 | $2.220 | 95,800 | |
| $2.490 | +0.040 | +1.6% | $2.620 | $2.620 | $2.350 | 213,500 | |
| $2.450 | +0.160 | +7.0% | $2.230 | $2.570 | $2.200 | 377,200 | |
| $2.290 | +0.160 | +7.5% | $2.100 | $2.350 | $2.100 | 213,343 | |
| $2.130 | -0.110 | -4.9% | $2.200 | $2.290 | $2.100 | 39,957 | |
| $2.240 | +0.050 | +2.3% | $2.180 | $2.340 | $2.170 | 70,500 | |
| $2.190 | -0.050 | -2.2% | $2.170 | $2.240 | $2.130 | 85,100 | |
| $2.240 | -0.060 | -2.6% | $2.230 | $2.350 | $2.160 | 80,200 | |
| $2.300 | +0.140 | +6.5% | $2.140 | $2.300 | $2.040 | 102,300 | |
| $2.160 | -0.110 | -4.8% | $2.150 | $2.250 | $2.130 | 32,700 | |
| $2.270 | -0.060 | -2.6% | $2.330 | $2.330 | $2.070 | 106,300 | |
| $2.330 | -0.030 | -1.3% | $2.340 | $2.350 | $2.170 | 287,100 | |
| $2.360 | 0.000 | 0.0% | $2.300 | $2.460 | $2.220 | 70,500 | |
| $2.360 | +0.010 | +0.4% | $2.260 | $2.380 | $2.240 | 46,600 | |
| $2.350 | +0.130 | +5.9% | $2.190 | $2.450 | $2.180 | 194,400 | |
| $2.220 | -0.010 | -0.4% | $2.190 | $2.270 | $2.140 | 46,200 | |
| $2.230 | -0.080 | -3.5% | $2.260 | $2.360 | $2.130 | 102,600 | |
| $2.310 | +0.090 | +4.1% | $2.210 | $2.500 | $2.210 | 163,900 | |
| $2.220 | +0.060 | +2.8% | $2.120 | $2.320 | $2.020 | 165,400 | |
| $2.160 | +0.140 | +6.9% | $2.000 | $2.240 | $1.950 | 240,500 | |
| $2.020 | +0.090 | +4.7% | $1.900 | $2.160 | $1.900 | 255,400 | |
| $1.930 | -0.050 | -2.5% | $1.990 | $1.990 | $1.850 | 113,600 | |
| $1.980 | -0.120 | -5.7% | $2.010 | $2.050 | $1.800 | 144,200 | |
| $2.100 | -0.400 | -16.0% | $2.260 | $2.500 | $1.930 | 290,400 | |
| $2.500 | -0.140 | -5.3% | $2.430 | $2.830 | $2.260 | 297,400 | |
| $2.640 | -0.420 | -13.7% | $2.960 | $2.980 | $2.560 | 303,100 | |
| $3.060 | -0.350 | -10.3% | $3.550 | $3.550 | $2.770 | 2,060,700 | |
| $3.410 | +1.550 | +83.3% | $6.490 | $6.850 | $3.000 | 79,569,700 | |
| $1.860 | -0.070 | -3.6% | $1.870 | $1.920 | $1.730 | 47,400 | |
| $1.930 | +0.040 | +2.1% | $1.870 | $1.970 | $1.840 | 35,100 |
- Ticker
- NASDAQ:LABT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 7, 2026
Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds
Latest deck · Sep 25, 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Latest news
Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds
Oct 7, 2026
Closed $0.85 (-2.3%) on Oct 7, 2026
Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
Oct 1, 2026
Closed $0.93 (-3.1%) on Oct 1, 2026
Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
Sep 28, 2026
Closed $1.15 (-31.1%) on Sep 28, 2026
Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3
Sep 21, 2026
Closed $2.05 (+3.0%) on Sep 21, 2026
Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
Sep 18, 2026
Closed $1.99 (+7.0%) on Sep 18, 2026
Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $2.18 (+16.0%) on Sep 8, 2026
Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
Jul 22, 2026
Closed $3.41 (+83.3%) on Jul 22, 2026
Lakewood-Amedex Biotherapeutics Announces Preclinical Safety Data Supporting Clinical Dose Selection for Upcoming Phase 2a Trial of Nu-3 Gel
Jul 15, 2026
Closed $2.43 (-4.7%) on Jul 15, 2026
Lakewood-Amedex Biotherapeutics Supports Reintroduction of the PASTEUR Act and Focus on Combating Antimicrobial Resistance
Jul 7, 2026
Closed $2.39 (-12.8%) on Jul 7, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 21 slides · Sep 25, 2026
Investor Presentation (July 2026)
Investor deck · 21 slides · Jul 15, 2026
Lakewood-Amedex Biotherapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 18 in all · newest Oct 7, 2026 · oldest 2026
- Decks
- 2 decks · latest Sep 25, 2026
Where Lakewood-Amedex Biotherapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LABT · Home listing · This page | NASDAQ | United States | USD |
| BOATS:LABT | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Lakewood-Amedex Biotherapeutics Inc.